Wells Fargo’s Immunomedics Inc IMMU Stock Holding History

Wells Fargo’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$2K	–	7162
2019 Q4	$2K	Sell	1,000 -9,000	-90%	-$159K	﹤0.01%	6212
2019 Q3	$4K	Sell	10,000 -2,000	-17%	-$29.4K	﹤0.01%	6126
2019 Q2	$13K	Hold	12,000	–	–	﹤0.01%	5869
2019 Q1	$44K	Buy	+12,000	New	+$193K	﹤0.01%	5355
2017 Q3	–	Sell	-86,600	Closed	-$179K	–	6558
2017 Q2	$179K	Buy	+86,600	New	+$608K	﹤0.01%	4853

Wells Fargo's IMMU Position: Q4 2020 in Review

Wells Fargo sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 860,762 shares — an estimated $73.2M sold.

Wells Fargo first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $73.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Wells Fargo reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Wells Fargo sold 860,762 Immunomedics Inc shares in Q4 2020, an estimated $73.2M.
Wells Fargo first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
Wells Fargo's Immunomedics Inc position peaked at $73.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.